Aims: Histology-based tumour microenvironment (TME) scores are useful in predicting the prognosis of gastrointestinal cancer. However, their prognostic roles in distal bile duct cancer (DBDC) have not been previously studied. This study aimed to evaluate the prognostic significance of the TME scores using the Klintrup-Mäkinen (KM) grade, tumour stroma percentage (TSP) and the Glasgow microenvironment score (GMS) in resected DBDC.
Methods And Results: Eighty-one patients with DBDC who underwent curative resection were enrolled. DBDC was graded according to KM grade, TSP and GMS. A high KM grade was found in 19 patients (24%) and a high TSP was found in 47 patients (58%). A high TSP was significantly correlated with a low KM grade (P < 0.001). The distribution of the GMS, which was developed by combining the KM grade and TSP, was as follows: 0 (n = 19, 24%), 1 (n = 19, 24%) and 2 (n = 43, 52%). A low KM grade, high TSP and high GMS were significantly associated with short overall survival (OS) (P < 0.001) and relapse-free survival (RFS) (P < 0.001). Furthermore, multivariate analysis showed that a low KM grade [hazard ratio (HR) = 3.826; confidence interval (CI) = 1.650-8.869; P = 0.014], high TSP (HR = 2.193; CI = 1.173-4.100, P = 0.002) and high GMS (HR = 7.148; CI = 2.811-18.173) were independent prognostic factors for short RFS; a low KM grade (HR = 4.324; CI = 1.594-11.733) and high GMS (HR = 6.332; CI = 2.743-14.594) were independent prognostic factors for short OS.
Conclusion: Histology-based TME scores, including the KM grade, TSP and GMS, are useful for predicting the survival of patients with resected DBDC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/his.14163 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Sinonasal Papillomas-An Up-To-Date Review for Practicing Pathologists.
Surg Pathol Clin
December 2024
Department of Pathology, University of Michigan Medical School, 3308 Rogel Cancer Center, 1500 E. Medical Center Drive, Ann Arbor, MI 48109, USA. Electronic address:
Sinonasal papillomas are a group of uncommon benign neoplasms that often represent a diagnostic challenge for surgical pathologists due to their diverse morphologic features. Our understanding of the molecular pathogenesis of these tumors has made significant advances recently that have reinforced the histology-based classification that was introduced over 50 years ago. As some subtypes have features that overlap with other sinonasal tumors, including specific carcinomas such as DEK::AFF2 nonkeratinizing squamous cell carcinoma, being aware of their key diagnostic findings is vital for appropriate classification.
View Article and Find Full Text PDFCancer of unknown primary and BRAF V600E meeting the BEACON combination: A case report.
Mol Clin Oncol
December 2024
Department of Gastroenterology and Hepatology, AZ Sint-Jan, 8000 Bruges, Belgium.
The diagnostic work-up of cancer of unknown primary (CUP) is a challenging task; in addition, only a little data on BRAF targeting in CUP are currently available. Traditionally, the identification of favourable and unfavourable CUP subsets directs the choice of treatment. The present article reports the case of a 50-year-old male patient presenting with a BRAF-mutated CUP, a rare and generally unfavourable subset.
View Article and Find Full Text PDFTyping of Vulvar Squamous Cell Carcinoma: Why it is Important?
Adv Anat Pathol
January 2025
Department of Pathology, Prince Sultan Military Medical Hospital, Riyadh, Saudi Arabia.
The classification of vulvar squamous cell carcinoma (VSCC), as in endometrial cancer, has shifted from the histology-based descriptors toward molecular-based identifiers. Recently, it has been reported that there are 3 genetically distinct and clinically significant subtypes of VSCC: HPV-associated VSCC, HPV-independent/p53 wild-type VSCC, and HPV-independent/p53-mutated VSCC. Each group has different prognostic implications as well as response to treatment, thus reinforcing the need for this 3-tier molecular classification.
View Article and Find Full Text PDFTarget-Driven Tissue-Agnostic Drug Approvals-A New Path of Drug Development.
Cancers (Basel)
July 2024
Division of Hematology & Medical Oncology, Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, OR 97239, USA.
The regulatory approvals of tumor-agnostic therapies have led to the re-evaluation of the drug development process. The conventional models of drug development are histology-based. On the other hand, the tumor-agnostic drug development of a new drug (or combination) focuses on targeting a common genomic biomarker in multiple cancers, regardless of histology.
View Article and Find Full Text PDFA New Histology-Based Prognostic Index for Aggressive T-Cell lymphoma: Preliminary Results of the "TCL Urayasu Classification".
J Clin Med
June 2024
Department of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi 279-0021, Japan.
Aggressive mature T-cell lymphoma (TCL) is a disease that carries a poor prognosis. We analyzed the expression of 22 tumor cell functional proteins in 16 randomly selected patients with TCL. Immunohistochemistry was performed in paraffin-embedded tumor tissue sections to determine the protein expression statuses in tumor cells.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!